Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
48.74
-1.16 (-2.32%)
Nov 21, 2024, 12:10 PM EST - Market open
Doximity Revenue
Doximity had revenue of $136.83M in the quarter ending September 30, 2024, with 20.44% growth. This brings the company's revenue in the last twelve months to $516.85M, up 15.29% year-over-year. In the fiscal year ending March 31, 2024, Doximity had annual revenue of $475.42M with 13.45% growth.
Revenue (ttm)
$516.85M
Revenue Growth
+15.29%
P/S Ratio
17.98
Revenue / Employee
$624,969
Employees
827
Market Cap
9.10B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Henry Schein | 12.50B |
Encompass Health | 5.22B |
Charles River Laboratories International | 4.06B |
Exact Sciences | 2.69B |
Exelixis | 2.08B |
Medpace Holdings | 2.07B |
Qiagen | 1.97B |
Sarepta Therapeutics | 1.64B |
DOCS News
- 6 days ago - Doximity Q2 Earnings: Positioning Is Paying Off - Seeking Alpha
- 13 days ago - Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday - Investopedia
- 13 days ago - Doximity Stock Soars 42% Toward Best Day Ever. It's Not the Only Record. - Barrons
- 13 days ago - Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Doximity Announces Fiscal 2025 Second Quarter Financial Results - Business Wire
- 20 days ago - Doximity to Present at the Jefferies London Healthcare Conference - Business Wire
- 4 weeks ago - Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024 - Business Wire
- 6 weeks ago - DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS - Business Wire